Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The pioneering work of members of the University, including research into tackling the Coronavirus pandemic, has been recognised in The Queen's Birthday Honours List.

Image of pipette and Oxford background

Recognised for their research and contributions to tackling the COVID-19 pandemic:

Sarah Gilbert, Professor of Vaccinology, who becomes a Dame Commander of the Most Excellent Order of the British Empire (DBE), for services to Science and Public Health. She is the Oxford Project Leader for ChAdOx1 nCoV-19, a vaccine against the novel coronavirus SARS-CoV-2, which is now in use in many countries around the world.

Adrian Hill, Director of the Jenner Institute and Lakshmi Mittal and Family Professor of Vaccinology, who becomes an honorary Knight Commander of the Most Excellent Order of the British Empire (KBE), for services to Science and Public Health. He has been a key member of the team that designed and developed the Oxford-AstraZeneca vaccine at the University’s Jenner Institute with the Oxford Vaccine Group.

Peter Horby, Director of the Pandemic Sciences Centre, and Professor of Emerging and Infectious Diseases and Global Health, who becomes a Knight Bachelor for services to Medical Research. He co-leads the UK Randomised Evaluation of COVID-19 therapy (RECOVERY) trial, the largest randomised controlled trial of COVID-19 treatments in the world.

Catherine Green, Head of the Nuffield Department of Medicine's Clinical Biomanufacturing Facility and Associate Professor at the Wellcome Centre for Human Genetics, who is appointed as an Officer of the Most Excellent Order of the British Empire (OBE), for services to Science and Public Health. Her team at the Clinical Biomanufacturing Facility has been an integral part of the University’s development of a ChAdOx1 vectored vaccine against the SARS-CoV-2 virus, in partnership with AstraZeneca.

Teresa Lambe, Associate Professor at the Jenner Institute, who is appointed as an honorary Officer of the Most Excellent Order of the British Empire (OBE), for services to Science and Public Health. She is one of the Principal Investigators overseeing the University’s Covid-19 vaccine programme.

Guy Thwaites, Professor of Infectious Diseases, is appointed a Member of the Order of the British Empire (MBE) for services to public health and UK/Vietnam relations. Professor Thwaites is Director of the Oxford Clinical Research Unit/Wellcome Programme in Vietnam, which studies emerging viral infections as well as conditions including malaria, tuberculosis and antimicrobial drug resistance. His personal research focuses on severe bacterial infections.

Professor Louise Richardson, Vice-Chancellor of the University of Oxford, said, ‘I am absolutely delighted by the recognition of our extraordinary colleagues who have worked so creatively and so tirelessly to develop a vaccine, and therapeutics, to protect us all from COVID-19. They and the teams that have supported them are saving lives around the world every day. We are all deeply proud of them.’

Similar stories

University of Oxford to launch Pandemic Sciences Centre

The University of Oxford has today announced the launch of a new centre of global research collaboration and excellence, the Pandemic Sciences Centre. The Pandemic Sciences Centre will harness the strong global research collaborations that the University of Oxford has developed over more than forty years. Its mission will be to ensure that the world is better equipped to create global, and equitable science-driven solutions to prepare for, identify, and counter future pandemic threats.

RECOVERY trial named David Sackett Trial of the Year 2020

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has been named David Sackett Trial of the Year by the Society for Clinical Trials (SCT). The award was presented today at the Society for Clinical Trials’ 42nd Annual Meeting.

Oxford University and Oracle partner to speed identification of COVID-19 variants

The partnership will enable global genomic sequencing and examination through a specialist platform developed on Oracle Cloud Infrastructure to help mitigate the impact of potentially dangerous COVID-19 variants.

Five new Academy of Medical Sciences Fellows from NDM

The Academy of Medical Sciences has elected 11 University of Oxford biomedical and health scientists to its fellowship five of which are from the Nuffield Department of Medicine. All were selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

Director of NDM's Jenner Institute elected to The Royal Society

Professor Adrian Hill, Director of the Jenner Institute becomes a Fellow for his leading role in the design and development of new vaccines for globally important infectious diseases over the course of over 25 years. He has demonstrated that non-replicating vectored vaccines, particularly simian adenoviruses used in heterologous prime-boost immunisation regimes, can protect safely through cellular as well as humoral immunity – supporting new vaccination approaches for malaria and Ebola.

National survey reveals big reductions in COVID-19 infections with single dose of Oxford-AZ and Pfizer vaccines

Data from the national COVID-19 Infection Survey, which is led by senior NIHR Oxford BRC researcher Professor Sarah Walker, has revealed the impact of vaccination on antibody responses and new infections in a large group of adults from the general population. This major community surveillance survey, one of the NIHR’s COVID-19 urgent public health studies, is a partnership between the University of Oxford, the Office of National Statistics (ONS) and the Department for Health and Social Care (DHSC).